scispace - formally typeset
A

Afshin Gangi

Researcher at University of Strasbourg

Publications -  349
Citations -  9329

Afshin Gangi is an academic researcher from University of Strasbourg. The author has contributed to research in topics: Cryoablation & Percutaneous. The author has an hindex of 48, co-authored 322 publications receiving 7988 citations. Previous affiliations of Afshin Gangi include St Thomas' Hospital & Louis Pasteur University.

Papers
More filters
Journal Article

Percutaneous vertebroplasty guided by a combination of CT and fluoroscopy.

TL;DR: The efficacy of the technique of percutaneous vertebroplasty using methyl methacrylate in preventing vertebral collapse could not be evaluated in this small sample; a well-controlled study would be required to determine the proper indications and efficacy.
Journal ArticleDOI

Imaging of cystic masses of the mediastinum

TL;DR: Familiarity with the radiologic features of mediastinal cystic masses facilitates accurate diagnosis, differentiation from other cystlike lesions, and, thus, optimal patient treatment.
Journal ArticleDOI

Percutaneous Vertebroplasty: Indications, Technique, and Results

TL;DR: The authors describe a dedicated therapeutic vertebroplasty technique that uses newly designed instruments, acrylic cement, and dual guidance with ultrasonography and computed tomography for pain control in patients with bone failure, and report their experience.
Journal ArticleDOI

Osteoid osteoma: percutaneous laser ablation and follow-up in 114 patients.

TL;DR: Percutaneous ILA is an effective treatment for osteoid osteoma and was considered successful when complete pain relief was achieved (VAS score, <1) without medication.
Journal ArticleDOI

Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the interventional oncology sans frontières meeting 2013

TL;DR: A consensus document making recommendations on the appropriate application of thermal ablation in patients with colorectal liver metastases is provided to facilitate judicious selection of the patients most likely to benefit from this technology and provide a unified interventional oncological perspective.